Solid Biosciences Inc's most recent insider trade came on January 31, 2023 by He served on the Board of Global Science and Technology for the National Academy of Sciences from 2009 to 2012, is the author of "The Great American Drug Deal" and "The Entrepreneurs Guide to a Biotech Startup", and frequently writes and speaks on the future of biotechnology innovation. Covid-19. New to Endpoints? They fell in love with the historic character and natural beauty of the area and, as they met more of the towns residents, realized that Woodstock was a community that they would like to be part of. $5M . 2004-2023 GuruFocus.com, LLC. Peter Kolchinsky usually trades in December, with the busiest year in 2022. But, as it often does, chance overrode plan, and they both fell in love with the property on the first visit. The oldest executive at Wave Life Sciences Ltd. is KojiMiura, 71, who is the Independent Director. Couple Number One: Peter and Anna Kolchinsky: Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Generic drugs are more often than not the unsung heroes in healthcare, generating billions in savings every year and increasing access to vital new medicines as the brand-name versions come off patent. Insider trading is most common in March, with the busiest year in 2015. Keri is also a writer and is currently working on a Southern gothic novel. While high-priced branded drugs make up only 11% of all prescriptions, they are the source of most pharmaceutical revenue ($237 billion in 2015). Ignoring warning calls from pharma companies and the Association of the British Pharmaceutical Industry (ABPI), the UK government announced its planning to raise the revenue clawback rate paid by pharmaceutical companies on the Statutory Scheme for Branded Medicines from 24.4% to 27.5%. I don't believe that temperature plays a role in the spread of Covid-19. It was written by our very kind neighbor, Hasse K. Halley. . Its a longstanding agreement between the government and industry to keep medicines affordable for the National Health Service (NHS). Stock quotes provided by InterActive Data. For a patient who can't afford a $5,000 deductible, even slashing a $50,000 treatment's price by 90% would still leave that patient unable to afford his or her $5,000 out-of-pocket obligation. Peter Kolchinsky, PhD '01, is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life sciences. Things here have been busy; were working hard to get the inn ready for our June 2010 grand opening. Hard work has helped him rise to the top. venue for exploring their particular passions. These are the three biggest challenges for innovators in large organizations and the three biggest enablers of success. Managing Partner | RA Capital Management Peter is a founder and Managing Partner at RA Capital Management, active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. Fundamental company data provided by Morningstar, updated daily. Adam Levy, CFO, Peter Kolchinsky's largest purchase order was 2,805,045 units , worth over Lefkofsky co-founded Groupon, is a trustee of many marquee Chicago institutions and co-manages the Midwest VC firm Lightbank, which is currently looking to raise $250 million for its third fund, per another document filed with the SEC last November. Shes currently earning her PhD in European History at Boston. I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss Peter Kolchinsky is a biotechnology investor and a scientist. Peter Kolchinsky, Ph.D. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. one-time use only and expires after 24 hours. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. He currently manages a fund that invests in healthcare and biotechnology companies. The current estimated net worth of Solid Biosciences Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . According to world-renowned virologist Peter Kolchinsky, the SARS-CoV-2 virus is nothing short of an "evil genius". Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. He holds a BA from Cornell University and a PhD in Virology from Harvard University. Over the last 8 years, insiders at Wave Life Sciences have traded over $18,606,802 worth of Wave Life Sciences stock and bought 14,319,108 units worth $106,704,225 Peter Kolchinsky: We need to see the difference between a true re-infection. Its certain to be a challenging one! The outspoken and occasionally caustic Kolchinsky is partnered with an urbane and widely-liked Shah. Peter Kolchinsky usually trades in February, with the busiest year in 2023. It was simply awesome! More than 100 drug developers thinned their organization charts last year. May 5, 2003 Like all mothers, Evelina Kolchinsky wanted her son, Peter, to adjust to school and do well. The Voluntary Scheme for Branded Medicines Pricing and Access is the second option, and typically has lower rates and is negotiated between the government and pharmas. var _Hasync=_Hasync||[];_Hasync.push(['Histats.start','1,4553220,4,511,95,18,00000000']);_Hasync.push(['Histats.fasi','1']);_Hasync.push(['Histats.track_hits','']);(function(){var hs=document.createElement('script');hs.type='text/javascript';hs.async=true;hs.src=('//s10.histats.com/js15_as.js');(document.getElementsByTagName('head')[0]||document.getElementsByTagName('body')[0]).appendChild(hs);})(); Peter Kolchinsky is a famous person who is known worldwide for his work. Peter Kolchinsky, Ph.D., has more than 18 years of experience in healthcare investing and is the founder of and a managing partner at RA Capital. He currently works with the State and Local Government Practice Group of the consulting firm Accenture. Our new neighbors have a vision for The Blue Horse Inn and have already started on renovations to make the house as vibrant from the outside as it is on the inside. See Peter Kolchinsky's compensation, career history, education, & memberships. Peter Kolchinsky is Chairman/CEO at Research Alliance Corp II. Peter's reported annual income is about $100 - 149,999; with a net worth that tops $50,000 - $99,999. Thus, plans for a second home for two quickly gave way to a new dream and a substantial life-style change for four. The estimated Net Worth of Peter Kolchinsky is at least $96 million dollars as of 23 June 2020. Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. GuruFocus.com is not operated by a broker or a dealer. Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High . The estimated Net Worth of Peter Kolchinsky is at least $105 Milion dollars as of 23 June 2020. Wave Life Sciences executives and other stock owners filed with the SEC include: Probieren Sie wallmine & ndash; es ist kostenlos. In addition, they want, Coming from diverse backgrounds and interests, the foursome. Peter Kolchinsky and Raj Shah have another $300 million-plus to play with on the biotech venture side of their investment business. Both Moffitt Cancer Center and Mayo Clinic in Florida, not too far from Domingos and his family, said he would have to wait between three and a half and four months to get the treatment. "And another thread that speaks to need for insurance reform. Come and visit me at the Pacific Water Conference, booth 520! Change). I am on Oahu until Friday, so please feel free to also contact me directly in order to discuss This investment adviser does not provide advice to individual investors. December 22nd, 2014. . The most active traders at the company are Required fields are marked *. Most recently he bought 6,337,135 units of KALA stock worth $49,999,995 on 13 March 2020 . In addition, he makes $151,598 as Independent Director at Wave Life Sciences. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Executives behind AI and precision medicine startup Tempus are putting together another AI outfit in Chicago focused on oncology drug discovery and development. Pathos AI is currently in the works and attempting to raise about $40 million, per an SEC filing from this week. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Change), You are commenting using your Facebook account. , Keri said, adding that she hopes the new business still allows her some time for her own writing. Most importantly, this book describes concrete, actionable reforms under which patients will be able to afford their treatments and society will continue to reap the benefits of medical innovation. In the last 5 years, insiders at Solid Biosciences Inc have sold an estimated value of $9.83M He studied philosophy at Oregon State University and then, a law degree from the University of Oklahoma. Peter's mailing address filed with the SEC is C/O RA CAPITAL MANAGEMENT, L.P., 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116. This slide deck contains a powerful visual illustration of the biotech industry's race to find a cure for Hepatitis C. Run through the slide deck quickly to appreciate the sheer level of hustle that won the world a cure, and then more slowly to appreciate every move in the chess game of mergers & acquisitions. and Peter Kolchinsky, Director Couple Number Two: Ben Ford and Keri Cole: Ben Ford was born and raised in Ames, Iowa. Carl Ashley Morris who sold 441 units worth In total, Peter Kolchinsky has made about 5 transactions over a year of their time at Solid Biosciences Inc. RA Capital Management, L.P. is the investment manager of RA Capital Healthcare Fund, L.P. With a few impressions we look back on this event and would like to thank very much all companies who made the North The company hired hundreds of new employees and paid . we figured our friends and family would try to talk us out of it, said Anna. The Statutory Scheme, which is governed under UK law, is one of two that companies can use. Dr. Kolchinsky's RA Capital held 9 million Forma Therapeutics Holdings, Inc. (NASDAQ:FMTX) shares worth $208.9 million which represented 2.89% of its portfolio during Q3. But there was a lot of adjusting to do, for everyone in the family. Currently, Peter is married. Add it to the rest of the money and their private deal capacity jumps to $1 billion, with $2.5 billion under management. As for their long-term goals, Peter and Ben are determined to figure out how to maintain the house themselves, from the roof to the plumbing, by the time they retire. The Great American Drug Deal was released on January 20, 2020. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and As of 23 June 2020 he still owns at least 9,011,651 units of Wave Life Sciences stock. The most active traders at the company are He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and reasonably well-trained dog. The current estimated net worth of Mineralys Therapeutics, Inc's Director, Peter Kolchinsky, is estimated to be about $2.92B . . Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc. Forbes and business insiders have done a recent study and say that Peter Kolchinsky net worth is more than a couple of million dollars. Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups John Carroll Editor & Founder Josh Resnick RA Capital Peter Kolchinsky and Raj Shah have another $300. https://t.co/y9IG2Z5txl" Tweet With huge thanks to RA Capital's Alex Martinez-Forte and Jacqueline Rhuda for extensive data analysis. Peter Kolchinsky's largest purchase order was 3,178,476 units , worth over By India Today Web Desk: With more than 22 lakh people infected, more than 1.5 lakh dead of the novel coronavirus, health experts all over the world are scrambling to understand just how did this one virus get so potent.. Unlock this article along with other benefits by subscribing to one of our paid plans. (LogOut/ Source: https://www.sec.gov/Archives/edgar/data/1818794/000119312521116286/d937458ddef14a.htm. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Dr. Peter Kolchinsky Ph.D. serves as Independent Director of the Company. They will be in plain English and use colorful analogies." The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Peters wife, Anna, grew up in Germany, Austria, and France, and came to Boston to attend Wellesley College. The current estimated net worth of Mineralys Therapeutics, Inc's Director, Peter Kolchinsky, is estimated to be about $2.7B . Other family members and associates include Alexander Kolchinsky, Evelina Kolchinsky, Anna Kolchinsky, Joseph Kolchinsky and Joseph Kolchinsky. In support of his arguments, he shared insights from government and industry professionals and cited facts and figures on the trajectory of the drug market. Hedge Fund Net Worth $4.93B Peter Kolchinsky manages more assets than 43% of other Hedge Fund Managers Average Return +0.32% Since Last Filing Last 12 Months 3 Years (Annualized) Portfolio Breakdown by Sector Portfolio Breakdown 97.31% Healthcare 1.12% Services 0.78% Technology 0.51% Financial RA Capital Management Portfolio Activity Company Name Peter Kolchinsky's largest purchase order was, In total, Peter Kolchinsky has made about, Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by Alfredo Naj Domingos prostate cancer was spreading. Anna is ex, cited about introducing her dressage horse, Im looking forward to some fishing. Peter, Anna, Ben and Keri can be found busily working at The Blue Horse Inn most weekends, often with friends and family, and invite the neighbors to stop in and say hello. This is where youll find the low down on whats happening in and around the BHI. A biotech analyst bets Novavax has the best data. After serving in the US Air Force JAG Corps, Ben, at a private law firm and in Massachusetts, He currently works with the State and Local Government Practice Group of. worked in film production in Berlin for several years before returning to Boston, where she met Peter. In the years Mineralys Therapeutics, Inc was active, insiders at Mineralys Therapeutics, Inc have bought an estimated value of $0 worth of shares. In the companys CLEAR study of nearly 14,000 patients, Esperions drug Nexletol cut the combined risk of heart attack, stroke, cardiovascular death or the need for coronary revascularization by 13%, compared with placebo. His wife, Nora Flor, said she and her sister made calls to at least 30 centers across the US looking for the drug. 2001 - Present22 years. Warren Buffett has made it clear. Let us know who we should consider our main ask is that you make the nominations personal. Data from the new InnoLead/KPMG US Peter Kolchinsky is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and. Peter Kolchinsky is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and. Refer a Friend and Earn One Month of Free Membership. Peter Kolchinsky The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines Paperback - Illustrated, January 17, 2020 by Peter Kolchinsky (Author) 180 ratings See all formats and editions Kindle $9.99 Read with Our Free App Audiobook $0.00 Free with your Audible trial Paperback Keri is currently the Chair of the Religious Studies department at St. Pauls School for Girls in Baltimore, Maryland. If you are considering starting your own biotech company, you will appreciate the wealth of practical information packed into The Entrepreneur's Guide to a Biotech Startup. You can see the complete history of Peter Kolchinsky stock trades at the bottom of the page. Peter Kolchinsky: It has infected people in different parts of the world. Peter Kolchinsky Net Worth The estimated Net Worth of Peter Kolchinsky is at least Wave Life Sciences stock worth over $36,046,604 and over the last 8 years he sold WVE stock worth over $58,095,632. So they invited their close friends Keri and Ben up for what they expected to be a reality check. $20M on February 16, 2023. It will take some time, but rest assured: a coronavirus vaccine is coming, and it will work. Your email address will not be published. Peter Kolchinsky, Ph.D. is a biotechnology investor and a scientist. He serves as a member of the board of directors of a number of private companies. To their delight, Keri and Ben, long-time city dwellers, were immediately taken with the town and the inn, and they, too, embraced the vision of a life filled with New England hospitality, nature, and, adds Ben, equal parts fly fishing and snow shoveling. She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. In addition, he makes $151,598 as Independent Director at Wave Life Sciences. Peter Kolchinsky owns about 2,805,045 units of Dyne Therapeutics, Inc common stock. Mineralys Therapeutics, Inc's most recent insider trade came on February 16, 2023 by This . Were not in a rush, Anna explained, and want to take some time to get to know the town. The singer-songwriter and actress is the latest celebrity addition to Merz Aesthetics Beauty on Your Terms campaign for Botox rival Xeomin. The URI to TrackBack this entry is: https://bluehorseinnvermont.wordpress.com/2010/03/14/the-blue-horse-six/trackback/. I would love for [the Blue Horse Inn] to be the kind of place that a writer just starting on a novel escapes to for hospitality and inspiration, Keri said, adding that she hopes the new business still allows her some time for her own writing. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. But many people worry that Covid-19 will mutate and . At least three dozen biotechs let employees go so far this year, based on Endpoints News reporting, with more having done so under the radar. and Ian F Smith, Director Peter Kolchinsky is 43, he's been the Independent Director of Wave Life Sciences since 2015. Ben Ford was born and raised in Ames, Iowa. Right now, he is the most trending person in social media. We'll e-mail you a link to set a new password. CB Rank (Investor) 53,342 Primary Job Title Portfolio Manager and Managing Director Primary Organization RA Capital Management Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male Investor Type Investment Partner LinkedIn View on LinkedIn But there was a new treatment he could try: a targeted radiotherapy called Pluvicto if he could get it in time. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. Before moving to Anna's current city of Boston, MA, Anna lived in Woodstock VT and Carlisle MA. As for Peter, As soon as we get the house in order, Im looking forward to some fishing. We loved the idea of having a second home that was also an inn, but we figured our friends and family would try to talk us out of it, said Anna. There are 12 executives at Wave Life Sciences getting paid more, with PaulBolno having the highest compensation of $3,581,530. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. Hbm Healthcare Investments Cayman Ltd who bought 3,218,106 units worth Kolchinsky Peter Ownership Network Ownership Network List of Kolchinsky Peter Name Position Linked company No Data Ownership Network Relation of Kolchinsky Peter Kolchinsky Peter Mailing Address Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. Catalys Pacific Fund Lp, The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The most recent stock trade was executed by Chandra Vargeese on 16 February 2023, trading 10,249 units of WVE stock currently worth $41,303. Carl Ashley Morris who sold, In the last 5 years, insiders at Solid Biosciences Inc have sold an estimated value of, Mailing address is 200 Berkeley Street 18th Floor Boston MA 02116 MA. In the interim, they plan to invite local folks in to see the changes, try out some wines, and make new friends. After serving in the US Air Force JAG Corps, Ben worked at a private law firm and in Massachusetts state government. This free 100-page eBook is based on personal interviews with entrepreneurs, investors, attorneys, and other professionals . Recently at Mineralys Therapeutics, Inc, Peter Kolchinsky has sold an estimated value of $0 worth. Many proposed solutions, including drug price controls, threaten to defund innovation but also distract the public from the real problem, which lies in the unraveling of the biotech social contract the implicit agreement between the biopharmaceutical industry and American society. She received her bachelors degree from Furman University in South Carolina in Philosophy and Asian Studies. He co-founded and runs the Boston-based investment firm RA Capital Management, writes and teaches about biomedical entrepreneurship and its potential to transform global health, serves on the boards of several public and private drug development companies, and has served on the Board of Global Science and Technology for the National . RA Capital is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are . He studied philosophy at Oregon State University and then earned a law degree from the University of Oklahoma. This new fund of theirs arrives well into a go-go era of new startup financing, with a particular focus on building new biotechs. Peter Kolchinsky grew up in the Boston area, studied biology at Cornell, and has a PhD in Virology from Harvard. This investment adviser does not provide advice to individual investors. On average, Wave Life Sciences executives and independent directors trade stock every 39 days with the average trade being worth of $949,631. Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. On average, Peter trades about 366,737 units every 19 days since 2014. Peter Kolchinsky. Quality, Value, Ownership Undervalued - Ebit/EV + B/M Blend Quality, Value, Momentum Activist Targets Dividend Yield Microcap with Revenue NCAV Screen Net Net Working Capital Negative Enterprise Value Piotroski Score ROIC Screen Short Volume Ratio High Insider Selling High Insider Buying Sometimes Anna goes by various nicknames including Anna H Kolchinsky, Anna I Haas, Anna Haas Kolchinsky and Anna Haas Kolchinsky. Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock.